uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Endothelial cell disease: emerging knowledge from cerebral cavernous malformations
Inst Mol Oncol Fdn, FIRC.;Mario Negri Inst Pharmacol Res..
Inst Mol Oncol Fdn, FIRC..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology. Inst Mol Oncol Fdn, FIRC.;Milano Univ, Sch Sci, Dept Biosci.;Milano Univ, Sch Med, Dept Oncol..
Inst Mol Oncol Fdn, FIRC..
2017 (English)In: Current opinion in hematology, ISSN 1065-6251, E-ISSN 1531-7048, Vol. 24, no 3, 256-264 p.Article, review/survey (Refereed) Published
Abstract [en]

Purpose of review Endothelial cells dysfunctions are crucial determinants of several human diseases. We review here the most recent reports on endothelial cell defects in cerebral cavernous malformations (CCMs), particularly focusing on adherens junctions. CCM is a vascular disease that affects specifically the venous microvessels of the central nervous system and which is caused by loss-of-function mutation in any one of the three CCM genes (CCM1, 2 or 3) in endothelial cells. The phenotypic result of these mutations are focal vascular malformations that are permeable and fragile causing neurological symptoms and occasionally haemorrhagic stroke. Recent findings CCM is still an incurable disease, as no pharmacological treatment is available, besides surgery. The definition of the molecular alterations ensuing loss of function mutation of CCM genes is contributing to orientate the testing of targeted pharmacological tools Several signalling pathways are altered in the three genotypes in a similar way and concur in the acquisition of mesenchymal markers in endothelial cells. However, also genotype-specific defects are reported, in particular for the CCM1 and CCM3 mutation. Summary Besides the specific CCM disease, the characterization of endothelial alterations in CCM has the potentiality to shed light on basic molecular regulations as the acquisition and maintenance of organ and vascular site specificity of endothelial cells.

Place, publisher, year, edition, pages
LIPPINCOTT WILLIAMS & WILKINS , 2017. Vol. 24, no 3, 256-264 p.
Keyword [en]
angiogenesis, cerebral cavernous malformation, endothelial cells, endothelial-to-mesenchymal transition
National Category
Hematology
Identifiers
URN: urn:nbn:se:uu:diva-331026DOI: 10.1097/MOH.0000000000000338ISI: 000400929700015PubMedID: 28212190OAI: oai:DiVA.org:uu-331026DiVA: diva2:1148261
Funder
Knut and Alice Wallenberg FoundationSwedish Research Council
Available from: 2017-10-10 Created: 2017-10-10 Last updated: 2017-10-10

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Dejana, Elisabetta
By organisation
Department of Immunology, Genetics and Pathology
In the same journal
Current opinion in hematology
Hematology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 34 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf